Table 1 Characteristics of studies included in the meta-analysis.
From: Influencing factors of medication adherence in schizophrenic patients: a meta-analysis
Author | Year | Study Design | Sample size N | Sample age M (SD) | Period | Diagnostic criteria | Influencing factors | References |
|---|---|---|---|---|---|---|---|---|
Olfson, M. | 2000 | Cohort study | 74 | 34.8 ± 9.7 | 18 months | DSM-IV | Substance abuse, past non-compliant behavior, family support | |
Acosta, F. J. | 2009 | Cohort study | 102 | 42.4 ± 11.7 | 3 months | ICD-10 | Insight, disease severity | |
Gearing, R. E. | 2009 | Cohort study | 65 | 15.35 ± 2.08 | at least 2 years | DSM-IV | Number of drugs | |
Hill, M. | 2010 | Cohort study | 104 | 29.1 ± 12.0 | 4 years | DSM-IV | Alcohol and drug abuse, duration of illness | |
Lambert, M. | 2010 | Cohort study | 605 | 15–29 | 18 months | DSM-IV | Number of medications, severity of illness, insight | |
Conti, V. | 2012 | Cohort study | 4975 | 46.4 ± 15.3 | 1 years | ICD-10 | Employment, city life, marriage, hospitalization | |
Hui, C. L. M. | 2016 | Cohort study | 313 | 38.2 ± 8.4 | 6 months | DSM-IV | Severity of illness, hospitalization at onset, social support, attitudes to treatment | |
Anderson, J. P. | 2017 | Cohort study | 308 | / | 1 years | DSM-IV | Psychological interventions, age, family support, alcohol and drug abuse, gender, education level, attitudes to treatment, social support | |
Conus, P. | 2017 | Cohort study | 584 | 22.1 ± 3.4 | 18 months | DSM-IV | Severity of illness, level of education, social support | |
Daneault, J. G. | 2019 | Cohort study | 421 | 14–35 | 2 years | DSM-IV | Alcohol or drug abuse, severity of illness | |
Desai, R. | 2019 | Cross-sectional study | 496 | / | / | ICD-9 | Gender, family support, level of education | |
Rezansoff, S. N. | 2019 | Cohort study | 1996 | 35.4 ± 9.4 | 17 months | ICD-9 | Attitude to treatment, amount of medication | |
Tan, C. Z. | 2019 | Cohort study | 445 | 26.3 ± 6.6 | 1 years | DSM-IV | Gender, family support, self-knowledge | |
Wang, D. | 2020 | Cross-sectional study | 1189 | 34.22 ± 12.29 | / | DSM-IV | Age, income, hospitalized at onset, severity of illness | |
Guitter, M. | 2021 | Cohort study | 136 | 29.5 ± 9.9 | 1 years | ICD-10 | Single, family support, hospitalized, other physical illness, active treatment | |
Rubio, J. M. | 2021 | Cohort study | 512 | / | 8 years | ICD-10 | Female, first hospitalization, other physical illness, age <25, substance abuse | |
Stockbridge, E. | 2021 | Cross-sectional study | 1778 | 18–64 | / | ICD-10 | Age >50, education, level of mental health, substance abuse, other physical illness | |
Verdoux, H. | 2021 | Cross-sectional study | 326 | 32.9 ± 0.4 | / | DSM-V | Number of drugs, efficacy, side effects, quality of life, psychological interventions, level of education, self-knowledge | |
Cho, S. J. | 2022 | Cohort study | 326917 | / | 6 months | ICD-10 | Sex, hospitalized at onset, income | |
Kirchner, S. K. | 2022 | Cross-sectional study | 1062 | 42.82 ± 12.98 | / | DSM-IV | Attitude to treatment, medication dose, quality of life, alcohol or drug abuse |
